Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
"The appeals court ruled, that class action watchdog Ted Frank of the Hamilton Lincoln Law Institute can intervene to protest $322,500 in mootness fees that pharmaceutical company Akorn agreed to pay to shareholder lawyers in exchange for their dismissal of lawsuits" @tedfrank https://t.co/WSGX2oKrZh
The U.S. Supreme Court was asked to strike down $667 million in legal fees and costs won by the plaintiffs’ lawyers in a $2.7 billion class-action settlement with Blue Cross Blue Shield accusing it of nationwide insurance overcharges @MikeScarcella https://t.co/SH8QDwpJod https://t.co/tKTFv7QmhU
Mallinckrodt's bankruptcy permitted the drug company to end a perpetual royalty agreement with Sanofi-Aventis involving the best-selling medication Acthar, the 3rd U.S. Circuit Court of Appeals ruled @DietrichKnauth https://t.co/vVhMj379rL https://t.co/wC3bDxLSCJ
A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort litigation over claims that Novo Nordisk and Eli Lilly failed to warn of the risks of side effects associated with diabetes and weight loss drugs. The order is considered unusual as it did not appoint lead counsel as requested by the plaintiffs. In a related development, lawyers suing over insulin pricing have abandoned their consumer class action settlement with Eli Lilly but remain committed to their case.